0.7739
Lexaria Bioscience Corp Aktie (LEXX) Neueste Nachrichten
Lexaria launches 2026 research program for drug delivery tech - Investing.com Nigeria
Lexaria launches 2026 research program for drug delivery tech By Investing.com - Investing.com Australia
Lexaria Announces New R&D Plans for 2026 - Investing News Network
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery - TipRanks
LEXX Initiates 2026 R&D Program to Enhance Pharma Innovations - GuruFocus
Biotech tests new oral GLP-1 formulas against Wegovy tablets - Stock Titan
Update Recap: Will Smith Douglas Homes Corp benefit from rate cuts2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
Is Lexaria Bioscience Corp. exposed to currency risksMarket Performance Recap & Technical Pattern Alert System - mfd.ru
Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability - The Globe and Mail
Aug Wrap: Is Lexaria Bioscience Corp a strong candidate for buy and holdEarnings Recap Summary & Weekly High Potential Stock Alerts - baoquankhu1.vn
Lexaria Bioscience: Oral Drug Delivery Technology Targets Next-Gen Weight Loss Market - The Globe and Mail
LEXX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
LEXX Should I Buy - Intellectia AI
Aug Intraday: Can Lexaria Bioscience Corp expand into new marketsJuly 2025 Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn
US Market Wrap: What are the risks of holding Hanover Bancorp IncMarket Growth Summary & Safe Capital Allocation Plans - baoquankhu1.vn
Update Report: Can Lexaria Bioscience Corp Equity Warrant sustain earnings growth2025 Dividend Review & Low Risk Investment Opportunities - baoquankhu1.vn
Published on: 2026-02-20 23:25:19 - baoquankhu1.vn
Will Lexaria Bioscience Corp. Equity Warrant stock go up in YEARJuly 2025 Selloffs & Entry Point Confirmation Signals - mfd.ru
Published on: 2026-02-20 04:22:15 - baoquankhu1.vn
Aug Intraday: Is Lexaria Bioscience Corp exposed to currency risksJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Aug Action: Will NHICU outperform tech stocksDip Buying & Verified Short-Term Trading Plans - baoquankhu1.vn
Is Lexaria Bioscience Corp. likely to announce a buyback2025 Support & Resistance & Entry Point Strategy Guides - mfd.ru
How Lexaria Bioscience Corp. Equity Warrant stock performs in interest rate cyclesQuarterly Earnings Summary & AI Optimized Trade Strategies - mfd.ru
Why Lexaria Bioscience Corp. stock could rally in 2025July 2025 Update & Real-Time Market Trend Scan - mfd.ru
Can Lexaria Bioscience Corp. ride the EV wave2025 AllTime Highs & AI Powered Market Entry Strategies - mfd.ru
Will Lexaria Bioscience Corp. stock attract ESG investorsMarket Trend Report & Entry and Exit Point Strategies - mfd.ru
LEXX PE Ratio & Valuation, Is LEXX Overvalued - Intellectia AI
Aug Momentum: Can Lexaria Bioscience Corp. Equity Warrant stock outperform in 2025 bull marketWatch List & AI Optimized Trading Strategy Guides - mfd.ru
Can Lexaria Bioscience Corp. Equity Warrant sustain earnings growthJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - mfd.ru
Research Analysts Set Expectations for LEXX Q2 Earnings - Defense World
Analysts Set Expectations for LEXX FY2028 Earnings - Defense World
Is Lexaria Bioscience Corp. Equity Warrant exposed to political riskRecession Risk & AI Driven Stock Price Forecasts - mfd.ru
Quarterly Earnings: Is Lexaria Bioscience Corp a strong candidate for buy and holdMarket Growth Summary & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Lexaria Bioscience Stock Price, News, Quote & History - Investing News Network
Bear Alert: Can Lexaria Bioscience Corp expand into new markets2025 Market WrapUp & Weekly Top Gainers Trade List - baoquankhu1.vn
Aug Swings: What is Lexaria Bioscience Corp Equity Warrants revenue forecastJuly 2025 Spike Watch & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Hedge Fund Moves: Does Lexaria Bioscience Corp have declining or rising EPSWeekly Stock Recap & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Lexaria Bioscience Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study - TipRanks
Lexaria Bioscience (LEXX) Demonstrates Promising Results in Late - GuruFocus
Lexaria Announces Positive Final Results from Human Pilot Study #5 - Investing News Network
Lexaria Announces Positive Final Results From Human Pilot Study #5 - The Joplin Globe
Experimental liraglutide pill shows similar results, 67% less nausea - Stock Titan
Signal Recap: Does Lexaria Bioscience Corp offer margin of safetyPortfolio Return Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
Aug Outlook: What is Lexaria Bioscience Corp. Equity Warrant s revenue forecastBreakout Watch & Fast Gaining Stock Reports - baoquankhu1.vn
Aug Levels: Can Lexaria Bioscience Corp sustain its profitabilityJuly 2025 Reactions & Accurate Entry/Exit Alerts - baoquankhu1.vn
Jobs Data: Will Lexaria Bioscience Corp Equity Warrant stock go up in YEAR2025 Growth vs Value & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Portfolio Recap: Is Lexaria Bioscience Corp Equity Warrant currently under institutional pressureJuly 2025 Volume & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Sectors: Is Lexaria Bioscience Corp exposed to political riskWeekly Trading Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):